Sirona Biochem Corp V.SBM

June presentation

[biorun]

Its posted.

One of the German posters (Tenibrother) pointed out a subtle but potential telling difference between the May and June presentation. I don't have the May presentation so if someone does, please double validate and tell us. If so, this was a good catch. Lets see if the market places any value on this tomorrow am at opening.

here is the google translation:

"TFC-039 is currently in multiple Phase I clinical trials and expected to complete in the first half of 2021 

What is striking compared to the May presentation is the underlining. 
Now everyone can decide for themselves whether this can happen during the revision / update. I think that was done consciously. 
That would be the end of this month."

[LakeOromocto]

May presentation reads the exact same.

[biorun]

I found the may presentation. Looks like Tenibrother was right. Same information but why underline now in a such a discrete way? If you look on this slide, they clearly went out of their way to underline the embedded target on this slide: Wanbang Biopharmaceuticals Agreement (2014) In January 2014, Sirona signed a license agreement with Wanbang

[forhandlaren]

Both human and vet in Phase I, that's my opinion. Howard has actually mentioned that the vet science for TFC-039 is working great but the legal part is slow. Since they are three partners, Sirona plus two more and only one of them has signed they cannot break the news. Perhaps Wanbang is one part, handling the science, and the other one co-finance.

[biorun]

The names of these potential parties are actually listed in recent disclosures. Market won't move until it has some indication that a deal will be signed. My theory is that there is some kind link between human clinical trial and pets deal. If we see Wanbang clear phase 1 then will pets go?  

[Pareto8020]

Howard was promoting the pet deal on the fact that animal testing requirements were much less stringent than the human trials and therefore a deal could be made in much less time and separate from the human testing.  Who knows what the new use for TFC039 is that could also be complicating timeframes.  I think it is related to weight loss but only time and Howard will tell.   

[biorun]

The share price went from 38 cents to now by moving the goal posts by 8 weeks and not showing a single material development on the list. We want him to communicate with us but we don't want any more information other than a material announcement. So his strategy was to do an interview.  I believe the second trial on healthy subjects produced an unexpected benefit correlated to varying

[MirrorWorldMan]

Revenue or buyout is the only thing thats going to add value to this stock

[biofool]

so the underlined sentence in the june presentation is now our last hope? nothing else, but nothing at all, seems to point to anything good. wanbang by Wednesday? nothing heard from faraway china for a long time. PRC, Mr. Billings & Tian... what about our unexplained shifts in the timeline from the may presentation? Pet Deal is silent since christmas. Silence means death in Sirona language

[sakinny3]

I have the April version and that says "expected to complete early 2021"